1 ion in determining pulmonary hemodynamics in left heart failure.

2 rtality in acute or chronic lung disease and left heart failure.

3 n hemodynamic abnormalities in patients with left heart failure and global and regional lung perfusio

4 hors highlight differences between right and left heart failure and outline key areas of future inves

5  and comorbidities such as coronary disease, left heart failure, and chronic obstructive pulmonary di

6 monary edema, high-altitude pulmonary edema, left heart failure, and overinflation of the lung.

7 ympathetic stimulation have been reported in left heart failure, but whether it would be beneficial f

8 een implicated in the development of chronic left heart failure, data describing such metabolic remod

9 rmance deteriorated, ultimately resulting in left heart failure (decompensated hypertrophy).

10    Contrasting with the major attention that left heart failure has received, right heart failure rem

11 nts with kidney failure and may be driven by left heart failure, high cardiac output from arterioveno

12 onally relevant heart disease, predominantly left heart failure in combination with right heart failu

13 55), pulmonary arterial hypertension without left heart failure (n=18), and control subjects (n=30) u

14 diac investigation revealed a combination of left heart failure, right heart failure and moderate-to-

15 y role of beta-blockers in the management of left heart failure, some authors have proposed to use th

16                                 In PH due to left heart failure the prevalence of AF was particularly